Lifetime risk assessment in cholesterol management among hypertensive patients: Observational cross-sectional study based on electronic health record data [post]

2020 unpublished
In hypertensive patients, reducing plasma low-density lipoprotein cholesterol level (LDL-C) is one of the main interventions for preventing chronic cardiovascular diseases (CVD). However, LDL-C control remains generally insufficient, also in patients with hypertension. We analyzed Electronic Health Record (EHR) data of 7117 hypertensive patients to find the most potential age and sex subgroups in greatest need for
doi:10.21203/rs.2.15336/v2 fatcat:ezveunv3wnfudledbufxhwm3oe